|
gptkbp:instanceOf
|
gptkb:public_company
|
|
gptkbp:acquiredBy
|
gptkb:US_Oncology
gptkb:Rexall
gptkb:PSS_World_Medical
|
|
gptkbp:category
|
Companies listed on the New York Stock Exchange
Companies based in Irving, Texas
Healthcare companies of the United States
|
|
gptkbp:CEO
|
gptkb:Brian_S._Tyler
|
|
gptkbp:chairman
|
gptkb:Donald_R._Knauss
|
|
gptkbp:country
|
gptkb:United_States
|
|
gptkbp:divested
|
gptkb:McKesson_Europe
gptkb:Change_Healthcare
|
|
gptkbp:founded
|
1833
|
|
gptkbp:founder
|
gptkb:John_McKesson
gptkb:Charles_Olcott
|
|
gptkbp:headquartersLocation
|
gptkb:San_Francisco,_California,_United_States
gptkb:Irving,_Texas,_United_States
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
McKesson Corporation
|
|
gptkbp:industry
|
healthcare
pharmaceutical distribution
|
|
gptkbp:notableEvent
|
COVID-19 vaccine distribution partner
Opioid litigation settlements
|
|
gptkbp:numberOfEmployees
|
approximately 48,500 (2023)
|
|
gptkbp:parentCompany
|
none
|
|
gptkbp:products
|
gptkb:insurance
pharmaceuticals
medical supplies
|
|
gptkbp:rank
|
Fortune 500 #9 (2023)
|
|
gptkbp:revenue
|
$264 billion (2023)
|
|
gptkbp:stockExchange
|
gptkb:NYSE
|
|
gptkbp:stockSymbol
|
gptkb:MCK
|
|
gptkbp:subsidiary
|
gptkb:McKesson_Canada
gptkb:McKesson_Medical-Surgical
gptkb:RelayHealth
|
|
gptkbp:website
|
https://www.mckesson.com/
|
|
gptkbp:bfsParent
|
gptkb:John_M._McKesson
gptkb:John_McKesson
gptkb:The_Woodlands,_Texas,_United_States
|
|
gptkbp:bfsLayer
|
5
|